Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus–Related Hospitalization

Is the risk of cardiorespiratory events elevated in the 180 days following respiratory syncytial virus (RSV)–related hospitalization in adults?In this self-controlled case series study of 11 887 patients, the risk of cardiorespiratory events after RSV-related hospitalization (especially during the first 2 weeks), including myocardial infarction, stroke, chronic obstructive pulmonary disease exacerbation, congestive heart failure exacerbation, and arrhythmia, was significantly higher than during the control period. This risk remained elevated up to 180 days for some cardiorespiratory events.The findings of this study highlight the extended RSV disease burden and the need to increase RSV immunization in adults.

Corresponding Author: Caihua Liang, MD, PhD, Pfizer Inc, 66 Hudson Blvd E, New York, NY 10001 (caihua.liang@pfizer.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.